NFKB1 and pulmonary fibrosis: The new anesthetic sevoflurane can downregulate the levels of p-IκB, p-P65, and P65 to inhibit NF-κB signaling pathway activation in PAH rat models, thereby reducing lung fibrosis and ultimately preventing PAH [50].